- Open Access
Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage
Journal of Pharmaceutical Policy and Practice volume 13, Article number: 19 (2020)
Coronavirus is causing a shortage of critical inhalers needed by patients with Asthma and respiratory illness. Patients with Asthma are at higher risk if they tract the novel Coronavirus. As the coronavirus continues to spread, hospitals are turning to use more salbutamol MDI. Salbutamol MDI has become the line of defence for physicians in the emergency room who are treating patients with Corona Virus Disease 2019 (COVID-19) and have respiratory distress .[Hui et al 2020 ,and Center for Drug Evaluation and Research 2020]
During the COVID pandemic, there has been a drastic increase in the use of MDI inhalers; therefore, it led to a decrease in availability and a break in the supply chain. Patients with Asthma are at higher risk if they tract the novel Coronavirus, and an inhaler could be a life or death for them. As the coronavirus continues to spread, hospitals are turning to use more salbutamol Metered Dose inhaler (MDI). Salbutamol MDI is now on short supply as the COVID-19 continues to spread. Salbutamol MDI has become the line of defence for physicians in the emergency room who are treating patients with COVID-19 and have respiratory distress. The current shortage of salbutamol MDI could be a result of stockpiling and hoarding of this life-saving inhaler. That had led to a critical shortage of Salbutamol MDI, and even the case shortage continues with some other alternatives such as Ipratropium MDI and even with long-acting B-agonists such as Salmeterol and Formoterol which also starting to have a limitation on ordering these agents.
Coronavirus sparks fear of medication shortage. Coronavirus panic-buying also may have led to a shortage of critical inhalers. We have also got elderly patients with COPD who may need Ventolin MDI and also premature babies who may have caught Respiratory Syncytial Virus (RSV) and need salbutamol MDI to support their lungs have since been compromised, and they rely heavily on Asthma inhalers. Finding a safe and creative strategy is essential during the COVID-19 pandemic.
Proposed sterilization plan for the used metered dose inhalers (MDI) [1,2,3,4]
There is considerable literature regarding the reprocessing and reuse of previously issued Salbutamol MDI. While a debatable practice, several hospitals have successfully implemented related programs .the current MDI canister protocol states that compliance with disinfecting the MDI nozzle is vital [5, 6]. In one case, cultures were taken of the MDI nozzle before and after disinfection with an alcohol prep pad, as well as after treatments were administered. Growth of Staphylococcus epidermidis occurred in at least 5% of the cultures with all three types of specimens, including those taken after the nozzle was disinfected with an alcohol prep pad. In another case, the hospital assessed the failure to wipe the canister nozzle with an alcohol prep pad before patient use; 1 of 18 (5.5%) cultures resulted in the growth of Streptococci Group D (Enterococci) . A discussion may need to take place in each institution that includes Doctors, infection control, and pharmacy to agree on the best way to implement and ensure safety.
Nebulized medication therapy has been the standard of care for bronchodilation for respiratory patients. However, nebulization generates aerosol, which increases the risk of droplet contamination as droplets can remain in the air and can spread virus particles. Critical inhaler medication shortage looms as coronavirus cases soar.
The use of metered-dose inhalers (MDI) reduces the risk of aerosol-generating particles. During the COVID pandemic, there has been a drastic increase in the use of MDI inhalers, which has led to a decrease in availability and a break in the supply chain. Hospital teams need to be proactive and start collecting the used MDI when appropriate and sterilize it following the provided procedure and keep in separate stock in case it is required. To minimize the risk of contamination, a discussion may need to take place in each institution that includes Doctors, infection control, SPD team and pharmacy to agree on the best way to implement and ensure safety (Fig. 1) (Table 1).
Availability of data and materials
Data sharing does not apply to this article as no datasets were generated or analyzed during the current study.
Revisiting the Need for MDI Common Canister Protocols During the COVID-19 Pandemic. Institute For Safe Medication Practiceshttps://www.ismp.org/resources/revisiting-need-mdi-common-canister-protocols-during-covid-19-pandemic (2020, accessed April 18, 2020).
Liou J, Clyne K, Knapp D, et al. Establishing a quality control program: ensuring safety from contamination for recycled metered-dose inhalers. Hospital pharmacyhttps://www.ncbi.nlm.nih.gov/pubmed/24958955 (2014, accessed April 20, 2020).
Pulmonary Disease Aerosol Delivery Deviceshttps://www.aarc.org/wp-content/uploads/2018/03/aersol-guides-for-hcp.pdf (accessed April 20, 2020).
Teva-Salbutamol HFA Inhalation Aerosol product monograph. Part III: Consumer Information: Cleaning Instructions. Page 26 of 27. .
Hui DS, Chow BK, Chu LCY, et al. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chesthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094435/ (2009, accessed April 20, 2020).
Center for Drug Evaluation and Research. Drug Shortages Response: COVID-19. U.S. Food and Drug Administrationhttps://www.fda.gov/drugs/coronavirus-covid-19-drugs/drug-shortages-response-covid-19 (accessed April 18, 2020).
Special Edition: Medication Safety Alert! April 3, 2020. Institute For Safe Medication Practiceshttps://ismp.org/acute-care/special-edition-medication-safety-alert-april-3-2020/covid-19 ().
I would like to acknowledge the support from the Pharmacy team in facilitating the data collection.
I know of no conflict of interest with this publication, and there has been no financial.
support for this work that could have influenced the outcome.
No known competing interest to declare.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Elbeddini, A. Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage. J of Pharm Policy and Pract 13, 19 (2020). https://doi.org/10.1186/s40545-020-00224-4
- Metered Dse inhalers (MDI)
- Drug shortage